Reported 2 days ago
With an investment of $5,000, consider buying shares of Eli Lilly and Vertex Pharmaceuticals in 2025. Eli Lilly has shown consistent innovation in diabetes and Alzheimer's treatments, promising long-term growth despite recent stock fluctuations. Vertex Pharmaceuticals, renowned for its breakthrough cystic fibrosis therapies, is also expanding its portfolio with promising pipeline treatments, making both companies excellent long-term investment candidates in the healthcare sector.
Source: YAHOO